revision cln3 manuscript supplement jci insight emedit...6-7mo areas of di!erence b c d-0.1 -0.05 0...

10
Supplementary Figures: Supplementary Figure 1: In early-stage disease there is no storage accumulation or neuronal loss. (A) Timeline of disease progression in the CLN3 -/- mouse. (B-D) Representative 10X images of the dentate gyrus (DG) show little autofluorescent storage material in 2-month-old WT or CLN3 disease mice. However, by 12 months, there is substantial accumulation. (E-I) At 2-months of age there is no CLN3-disease 2mo 6mo 10 15 20 25 30 NeuN Staining Intensity DG 2mo 6mo 0 5 10 15 NeuN Staining Intensity CA3 2mo 6mo 0 10 20 30 NeuN Staining Intensity CA1 B C D E F G H I 2mo WT DG 2mo CLN3 DG 12mo CLN3 DG A very-early stage early stage late stage very-late stage 2mo 6mo 12mo 18mo Storage, cell death Motor defects on rotorod J Dentate Hilus CA3 Oriens CA3 Radiatum CA1 Oriens CA1 Radiatum Perforant Path Mossy Fibers Schaer Collaterals To Cortex-> Perforant path stimulation site Schaer collaterals stimulation site 2mo CLN3 -/- NeuN 160μm 160μm 2mo WT NeuN 160μm

Upload: others

Post on 03-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figures:

Supplementary Figure 1: In early-stage disease there is no storage accumulation or neuronal loss. (A) Timeline of disease progression in the CLN3-/- mouse. (B-D) Representative 10X images of the dentate gyrus (DG) show little autofluorescent storage material in 2-month-old WT or CLN3 disease mice. However, by 12 months, there is substantial accumulation. (E-I) At 2-months of age there is no CLN3-disease

2mo 6mo10

15

20

25

30

Neu

N S

tain

ing

Inte

nsity

DG

WT

CLN3 KO

2mo 6mo0

5

10

15

Neu

N S

tain

ing

Inte

nsity

CA

3

WT

CLN3 KO

2mo 6mo0

10

20

30

Neu

N S

tain

ing

Inte

nsity

CA

1

WT

CLN3 KO

B C D

EF

G H I

2mo WT DG 2mo CLN3 DG 12mo CLN3 DG

Avery-earlystage

earlystage

latestage

very-latestage

2mo 6mo 12mo 18mo

Storage, cell death

Motor defects on rotorod

J

Dentate

Hilus

CA3 Oriens

CA3 Radiatum

CA1 Oriens

CA1 Radiatum

Perforant Path

Mossy Fibers

Scha

ffer

Colla

tera

ls

To Cortex->Perforant path stimulation site

Schaffer collaterals stimulation site

2mo CLN3-/- NeuN

160μm160μm

2mo WT NeuN160μm

Page 2: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

associated difference in staining of the neuronal marker NeuN in any of the major hippocampal subfields. E-F are representative NeuN images. G-I are quantification of staining intensity. N=4-5 animals / condition, mean +/- SEM shown, two-way ANOVA all p-values >0.05. (J) Schematic of hippocampal circuit and location of electrode placement for perforant path (as in studies of Fig. 1,2,4,5) and Schaffer collateral (as in studies of Fig. 3) stimulation studies.

Page 3: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 2: p-value maps confirm decreased activation of the dentate gyrus in response to PP stimulation in CLN3-/- mice. Results of permutation sampling statistical analysis (1000 permutations) of data from Figure 1 are shown with p-values <0.05 in purple. Dentate gyrus activation in response to perforant path stimulation is statistically different between WT and CLN3-/- slices at (A) 2 months, with more regions of statistical difference in the internal blade as compared to the external blade of the DG, (B) 6-7 months, and (C) 18-21 months of age. Group sizes (n=slices, N=mice): 2mo WT n=24, N=6; 2mo CLN3-/- n=26, N=5; 6-7mo WT n=23, N=5; 6-7mo CLN3-/- n=30, N=8; 18-21mo WT n=25, N=7; 18-21mo CLN3 n=26, N=7.

18-21 mo p-values

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

0 500 1000 15001

12

22

0 500 1000 15001

12

22

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

6-7 mo p-values

0 500 1000 15001

12

22

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

2 mo p-valuesA

B

C

Dentate Gyrus after PP stimulation

p-va

lue

0.05

1

0.1

0.01

0.001

Page 4: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 3: The CLN3Dex7/8 mouse, which models the most common human CLN3 mutation, also demonstrates hypoexcitability of the dentate gyrus early in the disease course. (A) Stimulation of the perforant path (location indicated by star) reveals robust excitation of the dentate gyrus (DG) in 6-7 month-old wild-type (WT) hippocampal slices, shown as a raster plot of average fluorescence change (DF/FWT). (B) By 6-7 months of age, the CLN3Dex7/8 DG is hypoexcitable (as measured by DF/FCLN3KO) as compared to WT after PP stimulation. (C) Results of permutation sampling statistical analysis (1000 permutations) comparing WT and CLN3Dex7/8 mice are shown with p-values <0.05 in purple. (D) . Regions of the raster plot with p>0.05 are masked in gray. For regions with p<0.05, the difference in fluorescence change (DF/FWT-DF/FCLN3KO) is shown. Cooler colors indicate relative hypoexcitability of the CLN3Dex7/8 DG. Group sizes (n=slices, N=mice): WT n=18, N=4; CLN3-/- n=24, N=5. Panel A reproduced from Figure 1D.

A

p-value

0.05 10.10.010.001

6-7 mo CLN3 delta 7/8

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

0 200 400 600 800time (ms)

1

12

22

0 200 400 600 800time (ms)

1

12

22

0 200 400 600 800 1000time (ms)

DGExternal

DGInternal

6-7 mo WT

0 500 1000 15001

12

22

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

6-7mo CLN3 delta 7/8 p-values

0 500 1000 1500time (ms)

1

12

22

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

6-7mo areas of difference B C D

0 0.05 0.1-0.05-0.1

ΔF/F (%)

Page 5: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 4: p-value maps comparing activation of the CA stratum radiatum of WT and CLN3-/- mice in response to perforant path (PP) and Schaffer collateral (SC) stimulation. Results of permutation sampling statistical analysis (1000 permutations) of data from Figure 2 and 3 are shown with p-values <0.05 in purple. Hilus, CA3 and CA1 activation in response to perforant path stimulation is minimally different between WT and CLN3-/-

slices at (A) 2 months. However, statistically significant regions of hypoexcitability in CLN3-/- slices is apparent at (B) 6-7 months, and (C) 18-21 months of age. Group sizes panels A-C (n=slices, N=mice): 2mo WT n=24, N=6; 2mo CLN3-/- n=26, N=5; 6-7mo WT n=23, N=5; 6-7mo CLN3-/- n=30, N=8; 18-21mo WT n=25, N=7; 18-21mo CLN3 n=26, N=7. Similar results are seen in response to SC stimulation, with minimal differences at (D) 2 months, but clear genotype-associated differences at (E) 6-7 months, and (F) 18-21 months of age. Group sizes panels D-F (n=slices, N=mice): 2mo WT n=13, N=5; 2mo CLN3-/- n=11, N=5; 6-7mo WT n=13, N=4; 6-7mo CLN3-/- n=11, N=3; 18-21mo WT n=13, N=4; 18-21mo CLN3-/- n=14, N=4.

A

B

C 18-21 mo p-values

0 200 400 600 800 1000time (ms)

0 500 1000 15001

36

Hilus

CA3

CA1

6-7 mo p-values

0 200 400 600 800 1000time (ms)

Hilus

CA3

CA1

0 500 1000 15001

36

2 mo p-values

0 200 400 600 800 1000time (ms)

Hilus

CA3

CA1

0 500 1000 15001

36

CA Stratum Radiatum afterPP stimulation

CA Stratum Radiatum afterSC stimulation

18-21 mo p-values

0 200 400 600 800 1000time (ms)

0 500 1000 15001

36

Hilus

CA3

CA1

6-7 mo p-values

0 200 400 600 800 1000time (ms)

Hilus

CA3

CA1

0 500 1000 15001

36

2 mo p-values

0 200 400 600 800 1000time (ms)

Hilus

CA3

CA1

0 500 1000 15001

36D

E

F

p-va

lue

0.05

1

0.1

0.01

0.001

Page 6: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 5: Carbenoxolone (CBX), a drug that reduces storage burden, cannot correct hypoexcitability of the dentate gyrus, and worsens hypoexcitability of the hilus and CA3 in early-stage CLN3 disease. (A-C) Hippocampal slices from 2-month-old mice treated with 2 weeks of 20mg CBX, a dose that reduces storage burden and normalizes endocytosis in vivo, show residual hypoexcitability of the dentate gyrus after perforant path (PP) stimulation, as measured by fluorescence response in CBX-treated WT vs CLN3-/- slices. (D-F) The hilus and CA3 regions of slices from CBX-treated CLN3-/- mice showed worsening hypoexcitability after Schaffer collateral (SC) stimulation. Group sizes (n=slices, N=mice): 2mo PP stimulation WT n=15, N=3; 2mo PP stimulation CLN3-/- n=25, N=5; 2mo SC stimulation WT n=17, N=4; 2mo SC stimulation CLN3-/- n=20, N=5. Areas of statistical significance identified using a permutation sampling method with 1000 permutations, for regions of significance with p<0.05, the difference in fluorescence change (DF/FWT-DF/FCLN3KO) is shown. Panel B reproduced from Figure 5B. Panel E reproduced from Figure 5E.

0 0.05 0.1-0.05-0.1

ΔF/F (%)

0 200 400 600 800time (ms)

1

12

22

0 200 400 600 800 1000time (ms)

DGExternal

DGInternal

A

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

0 200 400 600 800time (ms)

1

12

22B

0 500 1000 1500time (ms)

1

12

22

DGExternal

DGInternal

0 200 400 600 800 1000time (ms)

C

0 200 400 600 800 1000time (ms)

Hilus

CA3

CA1D

0 100 200 300 400 500 600 700 800 900time (ms)

1

36

0 200 400 600 800 1000time (ms)

Hilus

CA3

CA1E

0 100 200 300 400 500 600 700 800 900time (ms)

1

36

0 200 400 600 800 1000time (ms)

Hilus

CA3

CA1F

0 500 1000 1500time (ms)

1

36

WT + CBX CLN3KO + CBXWT + CBX vs.

CLN3KO + CBX

WT + CBX CLN3KO + CBXWT + CBX vs.

CLN3KO + CBX

Page 7: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 6: Example sharp wave ripple (SWR) detection from a WT animal. (A) Example 2 second raw EEG recording and (B) EEG signal filtered at 150-250Hz to show a SWR. (C) Example spectrogram analysis of the 1 second surrounding a SWR peak recorded from a WT hippocampus.

0 200 400 600 800 1000 1200 1400 1600 1800 2000-150

-100

-50

0

50

100

150

200

Hippocampal EEG voltage

0 200 400 600 800 1000 1200 1400 1600 1800 2000-80

-60

-40

-20

0

20

40

60

80 EEG filtered for SWR (150-250Hz)

200ms

300

150

200

250

100

50100200

300

400

500

600

700

800

900

1000

2 4 6 8 10

0

0.5

1

1.5

2

0-0.2-0.4 0.2 0.4Time (s)

power z-score

Freq

uenc

y (H

z)

A

B

C

Page 8: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 7: In early stage disease there are no differences between WT and CLN3-/- hippocampal sharp wave ripple (SWR) abundance or gamma power modulation during SWRs. (A) Quantification of SWRs per 30 min recording period from hippocampal EEG recordings of 6-month-old WT (black) and CLN3-/- (red) mice reveals no difference in SWR abundance (Mann-Whitney test p=0.51). (B) There was also difference in peak gamma power during an SWR (two-way ANOVA to evaluate animal and genotype variation, p=0.02 for genotype effect). (C-D) Average spectrograms from SWRs are similar between 6-month-old WT and CLN3 mice. Group sizes WT: 37 thirty-minute recording periods, 1334 SWRs, N=4 mice; CLN3-/- n=84 thirty-minute recording periods, 2040 SWRs, N=4 mice. Bar graphs show mean +/- SEM SWR number from all recording periods, black points show mean SWR abundance for each mouse.

A

0

10

20

30

40

50

SWR

s pe

r re

cord

ing

perio

d

WT CLN3 KO

ns

SWR abundance early-stage

0

2

4

6

8

Gam

ma

band

(25-

50 H

z)

pow

er z

-sco

re

WT CLN3 KO

ns

Gamma power during SWR early-stage

B

C D

Freq

uenc

y (H

z) 300

150200250

10050

0-0.1-0.2-0.3-0.4-0.5 0.1 0.2 0.3 0.4 0.5

WT SWR spectrogram early-stage

Time (s)

300

150200250

10050

0-0.1-0.2-0.3-0.4-0.5 0.1 0.2 0.3 0.4 0.5

Freq

uenc

y (H

z)

Time (s)

pow

er z

-sco

re9

8

7

6

5

4

3

2

1

100

150

200

250

300

1

2

3

4

5

6

7

8

9

CLN3 SWR spectrogram early-stage

Page 9: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 8: Unlike in control mice, hippocampal sharp wave ripples (SWR) in CLN3-/- mice trigger increased power in all frequency bands that lags behind and persists longer than the peak power in the SWR band. In the major EEG frequency bands including (A) delta (0.1-4 Hz), (B) theta (4-8 Hz), (C) alpha (8-13 Hz), (D) beta (13-25 Hz), (E) gamma (25-50 Hz) and (F) high gamma (50-100 Hz), there is increased power after a SWR in CLN3-/- (red) hippocampus as compared to WT (black). (G) While, in the SWR frequency range (150-250 Hz) there is no difference in power at the SWR peak. Group sizes for panels: WT n=2059 SWRs, N=7 mice; CLN3-/- n=1363 SWRs, N=7 mice. Graphs show mean +/- SEM. Groups compared using repeated measures two-way ANOVA followed Sidak’s multiple comparison test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

-0.5

-0.4

-0.3

-0.2

-0.1 0 0.1 0.2 0.3 0.4 0.5

0

1

2

3

Del

ta b

and

(0.1

-4 H

z)po

wer

z-s

core

**** *** ******** ****

********

****

**** ********

-0.5

-0.4

-0.3

-0.2

-0.1 0 0.1 0.2 0.3 0.4 0.5

0

1

2

3

4

Alph

a ba

nd (8

-13

Hz)

pow

er z

-sco

re

*** ** *** ********

****

****

****

**** ****

****

-0.5

-0.4

-0.3

-0.2

-0.1 0 0.1 0.2 0.3 0.4 0.5

0

1

2

3

Thet

a ba

nd (4

-8 H

z)po

wer

z-s

core

**** *** ******** ****

****

****

****

********

****

-0.5

-0.4

-0.3

-0.2

-0.1 0 0.1 0.2 0.3 0.4 0.5

0

2

4

6

8

Beta

ban

d (1

3-25

Hz)

pow

er z

-sco

re

* *****

****

****

****

********

****

-0.5

-0.4

-0.3

-0.2

-0.1 0 0.1 0.2 0.3 0.4 0.5

0

2

4

6

8

10

Gam

ma

band

(25-

50H

z)po

wer

z-s

core

****

****

****

****

********

-0.5

-0.4

-0.3

-0.2

-0.1 0 0.1 0.2 0.3 0.4 0.5

0

2

4

6

8

10

Hig

h ga

mm

a ba

nd (5

0-10

0 H

z)po

wer

z-s

core

********

****

**********

-0.5

-0.4

-0.3

-0.2

-0.1 0 0.1 0.2 0.3 0.4 0.5

0

2

4

6

8

SWR

ban

d (1

50-2

50 H

z)po

wer

z-s

core

* * ***

****

A B C D

E F G

Page 10: REVISION CLN3 Manuscript Supplement JCI Insight EMedit...6-7mo areas of di!erence B C D-0.1 -0.05 0 0.05 0.1 ΔF/F (%) Supplementary Figure 4: p-value maps comparing activation of

Supplementary Figure 9: In late-stage disease, there is no difference between WT and CLN3-/- hippocampal sharp wave ripple (SWR) duration. The duration of SWRs was calculated for all hippocampal ripples detected in WT (black) and CLN3-/- (red) 11-month-old mice. There was no significant difference in the (A) mean (p=0.43, Mann-Whitney test) or (B) cumulative fraction duration between groups. Bar graphs show mean +/- SEM duration of all SWRs, black points show mean SWR duration for each mouse.

A SWR duration late-stage SWR duration late-stageB

0

20

40

60

80

100

120

Dur

atio

n of

SW

R (m

s)

WT CLN3 KO

ns

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1Empirical CDF

SWR duration (ms)

Cum

mul

ativ

e Fr

actio

n

0 50 100 150 200 250

0.2

0.4

0.6

0.8

1.0

WT

CLN3 KO